Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Good
|
|
New words:
activin, antagonist, ASC, attributable, capture, Cardiology, Codification, COI, conference, convened, correct, deliverable, delivered, dispensed, dispensing, dossier, DSMB, error, exemption, expiration, hoc, inclusion, incorrect, learned, licensee, lieu, low, move, Neurocardin, nominated, par, point, ratably, reflect, restated, retroactive, Sci, Servier, Society, substantive, Tech, thereof, thereunder, unchanged, unpartnered, upfront, vendor, visit, Zensun
Removed:
Acceleron, accredited, acknowledgment, aging, bid, calendar, closing, customer, dated, decreased, delisted, delisting, demonstrating, determination, died, effectuate, generalized, inhibitor, listed, listing, myostatin, notification, penny, prolonged, promulgated, Rating, repaid, requirement, revised, score, stable, suddenly, suitability, tangible, written
Filing tables
Filing exhibits
Related press release
CYTK similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18. U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Cytokinetics, Incorporated on Form 10-Q for the quarterly period ended June 30, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Cytokinetics, Incorporated.
Dated: August 7, 2013
/s/ Robert I. Blum |
| Robert I. Blum |
| President and Chief Executive Officer |
| (Principal Executive Officer) |
/s/ Sharon A. Barbari |
| Sharon A. Barbari |
| Executive Vice President, Finance and |
| Chief Financial Officer |
| (Principal Financial Officer) |